Is Zevra Therapeutics, Inc. overvalued?

Zevra Therapeutics, Inc. (ZVRA) — key valuation metrics and fundamentals.

No verdict

Price

$11.32

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$669.2M

Dividend yield

0.0%

Return on equity

32.8%

Sector

Healthcare

Fair value compares ZVRA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks